PW MEDTECH 01358·

Gross margin 61.19%--55.67%5.52%56.42%0.76%54.55%1.87%49.48%5.07% Net margin 272.34%--24.01%248.33%30.37%6.36%25.04%5.33%16.42%8.61% ROE 19.49%--2.69%16.80%3.79%1.10%3.80%0.01%2.39%1.41% ROA 18.88%--2.58%16.30%3.98%1.40%3.73%0.25%2.58%1.15% Revenue growth ----97.80%--25.75%72.04%13.90%11.86%7.10%6.80% Attributable profit growth -----85.65%--44.46%130.11%-1.57%46.03%-37.41%35.84% Debt-to-assets 3.13%--7.05%3.91%6.35%0.70%6.93%0.58%7.29%0.36% Current ratio 24.82--11.5913.2313.612.0211.801.8110.890.91 Operating cash flow / net profit 0.05--2.092.041.031.061.650.621.780.13 Operating cash flow / revenue 13.72%--50.15%36.43%31.26%18.89%41.41%10.15%29.23%12.18%

Gross margin 51.35%--48.19%3.16% Net margin 20.90%--9.56%11.34% Revenue growth -----4.90%-- Attributable profit growth -----77.74%-- Debt-to-assets ----7.53%-- Current ratio ----9.38--

Revenue 271.40M--536.83M97.80%675.08M25.75%768.90M13.90%823.50M7.10% Gross profit 166.06M--298.82M79.95%380.90M27.46%419.45M10.12%407.46M2.86% Selling and distribution expenses 61.78M--67.47M9.21%76.09M12.77%84.08M10.51%96.65M14.95% Administrative expenses 65.23M--126.90M94.55%119.02M6.21%159.47M33.98%172.21M7.99% Net finance costs ----34.90M-------------- Income tax 1.65M--28.88M1647.13%26.04M9.82%37.23M42.95%29.74M20.12% Operating profit 680.73M--122.84M81.95%187.40M52.55%179.48M4.22%122.30M31.86% Profit before tax 737.46M--157.75M78.61%231.07M46.48%229.75M0.57%164.99M28.19% Net profit 739.12M--128.87M82.56%205.02M59.10%192.52M6.10%135.25M29.75% Net profit attributable to owners 739.12M--106.04M85.65%153.18M44.46%150.78M1.57%94.37M37.41%

Revenue 414.37M--394.06M4.90% Other income and gains 14.84M--5.45M63.26% Cost of sales 201.59M--204.15M1.27% Gross profit 212.78M--189.90M10.75% Selling and distribution expenses 43.77M--42.58M2.72% Administrative expenses 83.46M--93.45M11.97% Net finance costs 22.92M--14.64M36.15% Income tax 16.50M--13.15M20.34% Operating profit 80.20M--36.19M54.87% Profit before tax 103.12M--50.83M50.71% Net profit 86.62M--37.68M56.50% Net profit attributable to owners 66.00M--14.69M77.74%

Cash and cash equivalents 2.28B--1.38B39.52%1.59B15.03%1.68B5.81%1.80B7.19% Trade and bills receivables 148.33M--160.03M7.89%180.42M12.74%166.82M7.54%168.14M0.79% Inventories 33.18M--132.23M298.55%136.60M3.31%120.28M11.95%145.20M20.72% Total current assets 2.59B--1.95B24.96%2.03B4.39%2.09B3.08%2.36B12.75% Total assets 3.92B--4.99B27.43%5.15B3.27%5.16B0.17%5.24B1.44% Total current liabilities 104.47M--167.85M60.66%149.26M11.07%177.44M18.88%216.80M22.18% Total liabilities 122.64M--351.56M186.66%327.06M6.97%357.56M9.32%381.52M6.70% Equity attributable to owners 3.79B--3.95B4.03%4.04B2.51%3.97B1.80%3.95B0.53% Total equity 3.79B--4.64B22.29%4.82B4.04%4.80B0.45%4.85B1.05%

Cash and cash equivalents ----1.83B-- Trade and bills receivables ----147.57M-- Inventories ----170.85M-- Total current assets ----2.15B-- Total assets ----5.15B-- Total current liabilities ----228.94M-- Total liabilities ----387.24M-- Equity attributable to owners ----3.89B-- Total equity ----4.76B--

Net cash from operating activities 37.24M--269.23M622.91%211.03M21.62%318.43M50.89%240.70M24.41% Net cash from investing activities 2.64B---1.08B141.05%-26.66M97.54%-20.32M23.80%6.71M133.04% Net cash from financing activities -2.09B---85.16M95.93%17.53M120.59%-210.66M1301.46%-126.51M39.95% Net change in cash 582.36M---898.26M254.24%201.90M122.48%87.44M56.69%120.90M38.26%